There was no difference in the type of PAH, the WHO functional class, other functional parameters, NTproBNP level, the proportion of parenteral prostacyclin, combined therapy or home oxygen treatment between both groups. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.